End TB.
Accessed in November 2017.
The modules (1-12) are based on materials originally developed by FIND, KNCV and Cepheid, and are in PowerPoint format for country customization. Depending on the audience, modules may be selected and adapted according to need (e.g. basic users, supervisors, clinicians). Topics covered include: Over...view of TB and diagnostics, biosafety, specimen collection, procurement, installation, Xpert MTB/RIF technology, results interpretation, reporting, troubleshooting, maintenance, a clinical guide, and quality assurance.
Please download each manual directliy from the website
more
13280–13285 / PNAS / September 9, 2008 / vol. 105 / no. 36
Harm Reduction Journal (2016) 13:28
DOI 10.1186/s12954-016-0118-x
Reprinted from Australian Family Physician Vol. 39, No. 10, october 2010
Emerging Infectious Diseases Vol. 16, No. 5, May 2010
Towards ending tuberculosis and multidrug-resistant tuberculosis.
Lancet Respir Med 2017; 5: 291–360Vol, 5 April 2017
Journal of Infectious Diseases and Therapeutics, 2013, 1, 17-24
Policy
25 February 2015 Vol 7 Issue 276 276fs8
54th directing council; 67th session of the regional Committee of WHO for the Americas
CD54/11, Rev. 1, 2 October 2015, Original: Spanish
Euro Surveillance 2014;19(47):pii=20970, p.31-37